Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 14.05.2024 / 11:07 CET/CEST The issuer is solely responsible for the content of this announcement. 1. Details of the person discharging managerial responsibilities / person closely associated a) Name Name and legal form: | be executive GmbH | 2. Reason for the notification a) Position / status Person closely associated with: | Title: | | First name: | Bruno | Last name(s): | Wohlschlegel | Position: | Member of the managing body | b) Initial notification 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name b) LEI 4. Details of the transaction(s) a) Description of the financial instrument, type of instrument, identification code Type: | Share | ISIN: | DE000A3CMGM5 | b) Nature of the transaction c) Price(s) and volume(s) Price(s) | Volume(s) | 8.88 EUR | 8880.00 EUR | d) Aggregated information Price | Aggregated volume | 8.8800 EUR | 8880.0000 EUR | e) Date of the transaction f) Place of the transaction Name: | Tradegate | MIC: | TGAT | 14.05.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com |
Language: | English |
Company: | APONTIS PHARMA AG |
| Alfred-Nobel-Str. 10 |
| 40789 Monheim |
| Germany |
Internet: | https://apontis-pharma.de/ |
|
End of News | EQS News Service |
91495 14.05.2024 CET/CEST